自体腹膜移植回肠浆肌扩大原位膀胱的重建

目的为探求一种理想的肠代膀胱重建的方法,设计并建立腹膜自体移植回肠膀胱重建的小型猪实验动物模型。方法随机选取封闭饲养的雌性成年实验用小型猪6只,体重28～33 kg,在全麻下行回肠浆肌层腔外直接剥离术+膀胱部分切除术+膀胱重建手术(将选取的自体腹膜覆盖于带血供的回肠浆肌层表面制备成复合游离瓣膜,将其与膀胱残垣进行吻合修补重建新膀胱),术后5 d拔除双侧输尿管导管,7 d拔除气囊支撑尿管,观察排尿情况。术后12周在麻醉下行膀胱造影及尿流动力学检查,之后予安乐处死动物,取出膀胱标本进行常规病理学、免疫组织化学及电镜检查。结果将6只猪进行手术实验,6只动物术后正常存活,无1只死亡,无腹膜炎、肠梗阻或尿瘘等并发症发生。移植腹膜-回肠浆肌复合游离瓣膜均全部成活,术后拔除尿管观察动物排尿可,黄清,与术前对比无差异。术后膀胱形态及功能与术前比较无差异。病理学显示,术后12周可见重建膀胱部位所覆盖腹膜完全被尿路移行上皮取代,未见回肠上皮细胞再生与残留。扫描电镜观察显示,重建膀胱部分移行上皮完整致密、排列整齐,吻合交界处膀胱黏膜移行细胞连续,无中断及错位。结论在动物(猪)腔外回肠浆肌剥离与自体腹膜移植替...     

Relation of genetic polymorphisms in microRNAs with diastolic and systolic function in type 2 diabetes mellitus

Background and aimsType 2 diabetes mellitus (T2DM) has high risk of developing cardiac dysfunction, increasing of either cardiovascular death or hospitalization for heart failure. MicroRNAs (miRNA) affect cardiac function of T2DM. The aim of this study was to investigate the relationships between five miRNA single nucleotide polymorphisms (SNP) and diastolic and systolic function of T2DM.Methods and resultsThree hundred untreated T2DM subjects were included. Each subject underwent SNP genotyping, conventional echocardiography, tissue doppler imaging, and speckle tracking imaging. The effects of miRNA SNPs on diastolic and systolic function were evaluated. The diastolic function of T2DM subjects with miR-133a-1-rs8089787 wild genotype or let-7f-rs10877887 variant genotype was lower than those with miR-133a-1-rs8089787 variant genotype or let-7f-rs10877887 wild genotype, manifesting as higher left atrial volume index, lower mean E′, and higher E/E’ (P < 0.05). There were no significant effects of miR-133a-2-rs13040413, let-7a-1-rs13293512 and miR-27a-rs895819 on the diastolic function of T2DM subjects (P > 0.05). These five miRNA SNPs had no effect on the systolic function of T2DM subjects (P > 0.05).ConclusionsMiRNA-133a-1-rs8089787 and let-7f-rs10877887 were associated with impaired cardiac diastolic function in T2DM. The findings may be a promising therapeutic targets for preventing diastolic dysfunction in T2DM.     

Individual and combined relationship of serum uric acid and alanine aminotransferase on metabolic syndrome in adults in Qingdao,China

Background and aimsAssociations of alanine aminotransferase (ALT) and serum uric acid (SUA) with metabolic syndrome (MetS) remain controversial. We aimed to explore individual and combined effects of ALT and SUA on MetS in community residents.Methods and resultsA population-based cross-sectional survey involving randomly selected Chinese adults aged 35–74 years was conducted in 2009 in Qingdao, China, and 4642 participants were included in the current study. Based on a combination of SUA and ALT levels in the tertile, subjects were grouped into Group 1-9. The individual and combined relations of SUA and ALT to MetS were analyzed by logistic regression models. The prevalence of MetS was 28.50% in males and 22.30% in females. ALT and SUA were independently associated with MetS and ORs (95% CIs) were 1.55 (1.42–1.70) and 1.92 (1.72–2.14), respectively, after adjusting for potential confounders. With the elevation of ALT and SUA levels, the risk of developing MetS increased. Compared to Group 1, ORs (95% CIs) of combined ALT and SUA for MetS were 2.21 (1.70–2.88), 4.02 (3.10–5.21), 2.19 (1.62–2.97), 2.53 (1.91–3.34), 4.69 (3.60–6.12), 1.76 (1.17–2.64), 3.65 (2.63–5.06) and 7.15 (5.41–9.46) in Group 2–9, respectively.ConclusionsALT and SUA were both related to MetS independently. Combined elevation of ALT and SUA levels could increase the risk of MetS and its components than an elevation in SUA and ALT alone. Therefore, measures should be taken to lower SUA and ALT levels to reduce the risk of having MetS.     

Validating an ontology-based algorithm to identify patients with Type 2 Diabetes Mellitus in Electronic Health Records

BackgroundImproving healthcare for people with chronic conditions requires clinical information systems that support integrated care and information exchange, emphasizing a semantic approach to support multiple and disparate Electronic Health Records (EHRs). Using a literature review, the Australian National Guidelines for Type 2 Diabetes Mellitus (T2DM), SNOMED-CT-AU and input from health professionals, we developed a Diabetes Mellitus Ontology (DMO) to diagnose and manage patients with diabetes. This paper describes the manual validation of the DMO-based approach using real world EHR data from a general practice (n = 908 active patients) participating in the electronic Practice Based Research Network (ePBRN).MethodThe DMO-based algorithm to query, using Semantic Protocol and RDF Query Language (SPARQL), the structured fields in the ePBRN data repository were iteratively tested and refined. The accuracy of the final DMO-based algorithm was validated with a manual audit of the general practice EHR. Contingency tables were prepared and Sensitivity and Specificity (accuracy) of the algorithm to diagnose T2DM measured, using the T2DM cases found by manual EHR audit as the gold standard. Accuracy was determined with three attributes – reason for visit (RFV), medication (Rx) and pathology (path) – singly and in combination.ResultsThe Sensitivity and Specificity of the algorithm were 100% and 99.88% with RFV; 96.55% and 98.97% with Rx; and 15.6% and 98.92% with Path. This suggests that Rx and Path data were not as complete or correct as the RFV for this general practice, which kept its RFV information complete and current for diabetes. However, the completeness is good enough for this purpose as confirmed by the very small relative deterioration of the accuracy (Sensitivity and Specificity of 97.67% and 99.18%) when calculated for the combination of RFV, Rx and Path. The manual EHR audit suggested that the accuracy of the algorithm was influenced by data quality such as incorrect data due to mistaken units of measurement and unavailable data due to non-documentation or documented in the wrong place or progress notes, problems with data extraction, encryption and data management errors.ConclusionThis DMO-based algorithm is sufficiently accurate to support a semantic approach, using the RFV, Rx and Path to define patients with T2DM from EHR data. However, the accuracy can be compromised by incomplete or incorrect data. The extent of compromise requires further study, using ontology-based and other approaches.     

我国新生儿窒息复苏指南基本论点及新热点

2004年卫生部妇幼保健与社区卫生司在全国开展新生儿窒息复苏培训项目，其目标为5年内在我国建立一个遍及全国的、掌握新生儿窒息复苏技术的人才队伍，确保我国每家医院的每个分娩现场至少有1名受过复苏培训、掌握新生儿复苏技术的医护人员在场。并在2004年组织专家制订结合我国国情的中国新生儿窒息复苏指南。本文介绍“指南”基本论点及窒息复苏的某些新热点。     

Polygenic risk scores and risk-stratified breast cancer screening: Familiarity and perspectives of health care professionals

PurposeHealth care professionals are expected to take on an active role in the implementation of risk-based cancer prevention strategies. This study aimed to explore health care professionals’ (1) self-reported familiarity with the concept of polygenic risk score (PRS), (2) perceived level of knowledge regarding risk-stratified breast cancer (BC) screening, and (3) preferences for continuing professional development.MethodsA cross-sectional survey was conducted using a bilingual—English/French—online questionnaire disseminated by health care professional associations across Canada between November 2020 and May 2021.ResultsA total of 593 professionals completed more than 2 items and 453 responded to all questions. A total of 432 (94%) participants were female, 103 (22%) were physicians, and 323 (70%) were nurses. Participants reported to be unfamiliar with (20%), very unfamiliar (32%) with, or did not know (41%) the concept of PRS. Most participants reported not having enough knowledge about risk-stratified BC screening (61%) and that they would require more training (77%). Online courses and webinar conferences were the preferred continuing professional development modalities.ConclusionThe study indicates that health care professionals are currently not familiar with the concept of PRS or a risk-stratified approach for BC screening. Online information and training seem to be an essential knowledge transfer modality.     

不同疾病状态下新生儿脑组织氧合变化的对照研究

目的采用近红外光谱测定技术（NIRS）检测新生儿脑组织氧饱和度（rSO2）,探讨不同疾病状态下新生儿脑rSO2的变化规律,为临床应用提供依据。方法2007年4月至2008年10月以无特殊疾病的223名足月儿作为正常组足月儿亚组,于生后3d内测定脑rSO2;以196例患有可能影响脑氧合疾病的新生儿作为疾病组,在疾病急性期测定脑rSO2。疾病组分为呼吸系统疾病亚组（97例）,分析脑rSO2与PaO2的关系;循环系统疾病亚组（44例）,分析脑rSO2与心率的关系;脑损伤亚组（55例）,分析脑rSO2与脑血流的关系。结果①疾病组脑rSO2为（56±6）%,显著低于正常组足月儿亚组（P〈0.05）。②轻度与重度呼吸系统疾病亚组脑rSO2分别为（60±3）%和（54±6）%,轻度和重度循环系统疾病亚组脑rSO2分别为（59±3）%和（53±6）%,轻度和重度脑损伤亚组脑rSO2分别为（59±3）%和（54±4）%。3个疾病亚组中轻度与重度间脑rSO2差异均有统计学意义（P〈0.01）。③呼吸系统疾病亚组脑rSO2与PaO2呈三次方程曲线（y=-62.93＋4.75x-0.059x2＋0.00024x3）。PaO2≥60mmHg时,脑rSO2约为62%,脑氧合正常;PaO2〈50mmHg时,脑rSO2〈57%,脑组织缺氧。循环系统疾病亚组脑rSO2与心率呈二次方程曲线（y=1.11＋0.8241x-0.0027x2）。心率在105～200.min-1时,脑rSO2〉58%,脑氧合正常;心率低于105.min-1或高于200.min-1时,脑rSO2〈58%,脑组织缺氧。脑损伤亚组脑rSO2〈58%时,大脑前动脉血流平均速度代偿性增高,阻力指数偏低,脑损伤较重。结论严重疾病状态下可同时伴有脑组织缺氧。脑rSO2的变化与PaO2、心率及脑血流的变化密切相关。NIRS技术为临床提供了一种可靠的、有价值的脑氧合检测方法,有助于临床直观量化地发现脑组织的缺氧。     

Potential reductions in ultra-processed food consumption substantially improve population cardiometabolic-related dietary nutrient profiles in eight countries

Background and aimsThe negative effect on dietary nutrient profiles is the most obvious mechanism explaining the higher risk of cardiometabolic diseases associated with increased dietary share of UPF observed in large cohort studies.We estimate the proportion of diets with excessive energy density, excessive free sugars or saturated fat contents and insufficient fiber that could be avoided, if UPF consumption was reduced to levels among lowest consumers across eight countries, as well as the proportion of diets with multiple inadequacies.Methods and resultsUsing nationally-representative cross-sectional surveys from Brazil (2008–09), Chile (2010), Colombia (2005), Mexico (2012), Australia (2011–12), the UK (2008–16), Canada (2015), and the US (2015–16), inadequate energy density (≥2.25 kcal/g) or contents of free sugars (>10% of total energy intake), saturated fats (>10% of total energy intake) and fiber (<25 g/2000 kcal) population attributable fractions were quantified.Substantial reductions in nutrient inadequacies would be observed ranging from 50.4% in Chile to 76.8% in US for dietary energy density, from 15.5% in Colombia to 68.4% in Australia for free sugars, from 9.5% in Canada to 35.0% in Mexico for saturated fats, and from 10.3% in UK to 37.9% in Mexico for fiber. Higher reductions would be observed for diets with multiple nutrient inadequacies: from 27.3% in UK to 77.7% in Australia for ≥3 and from 69.4% in Canada to 92.1% in US, for 4 inadequacies.ConclusionsLowering dietary contribution of UPF to levels among country-specific lowest consumers is a way to improve population cardiometabolic-related dietary nutrient profiles.     

糖尿病患者的位听功能状况分析

目的评价糖尿病患者位听功能状况,探讨糖尿病与位听功能变化的关系。方法回顾分析2011年1月至2011年12月,因眩晕就诊于首都医科大学附属北京同仁医院耳鼻咽喉头颈外科的137例2型糖尿病患者,分析其位听功能的变化。结果在被调查的137例受试者中:①85例(62.04%)患者存在听力损失,其中糖尿病病程≤10年者115人,65例(56.52%)患者存在不同程度听力损失;糖尿病病程>10年者22人,听力损失者20例(90.90%)。糖尿病患者的听力损失与病程有关,病程长的糖尿病患者听力损失发生率高(P=0.001);②114例(84.44%)患者存在前庭功能受损,94例(68.61%)存在耳鸣,49例(35.77%)主诉耳闷堵感;③糖尿病患者听力损失与性别有关(OR=2.076),男性较女性患者听力损失发生率高(P=0.073)。结论 2型糖尿病患者的听力损失发生率高,且与患者性别和糖尿病病程有关。病程长的糖尿病患者听力损失发生率高,男性患者尤其显著。